Lung transplantation for idiopathic pulmonary fibrosis.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 17888957)

Published in Ann Thorac Surg on October 01, 2007

Authors

David P Mason1, Mariano E Brizzio, Joan M Alster, Ann M McNeill, Sudish C Murthy, Marie M Budev, Atul C Mehta, Omar A Minai, Gösta B Pettersson, Eugene H Blackstone

Author Affiliations

1: Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA. masond2@ccf.org

Articles citing this

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One (2010) 1.53

Bilateral lung transplantation offers better long-term survival, compared with single-lung transplantation, for younger patients with idiopathic pulmonary fibrosis. Ann Thorac Surg (2011) 1.41

Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12

Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med (2013) 1.04

Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis. PLoS One (2014) 0.96

Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread. Crit Care (2010) 0.93

Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. BMC Pulm Med (2014) 0.87

Idiopathic pulmonary fibrosis: early detection and referral. Respir Med (2014) 0.82

Approach to acute exacerbation of idiopathic pulmonary fibrosis. Ann Thorac Med (2013) 0.79

Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts. PLoS One (2016) 0.78

Targeting sphingosine-1-phosphate signaling in lung diseases. Pharmacol Ther (2016) 0.76

Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation. Lung (2015) 0.75

Articles by these authors

Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04

Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23

Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33

Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21

Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77

Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59

7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52

A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46

Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer (2010) 4.40

Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87

Central airway obstruction. Am J Respir Crit Care Med (2004) 3.62

Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50

Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47

Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: validation of a contemporary surgical experience. Eur J Cardiothorac Surg (2012) 3.41

Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37

Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35

Use of annulus washer after debridement: a new mitral valve replacement technique for patients with severe mitral annular calcification. J Thorac Cardiovasc Surg (2013) 3.31

The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25

Counterpoint: Are the CHEST guidelines global in coverage? No. Chest (2015) 2.88

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78

Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76

Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA (2011) 2.73

Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.67

Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med (2013) 2.64

Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.55

Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.47

Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42

Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42

Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med (2006) 2.40

Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg (2004) 2.37

A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31

Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation (2005) 2.26

Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26

Are all readmissions bad readmissions? N Engl J Med (2010) 2.22

Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20

Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20

Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18

Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16

A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13

Editorial: An 'actual' problem: Another issue of apples and oranges. J Heart Valve Dis (2005) 2.11

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09

Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08

Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07

Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06

Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04

The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg (2004) 2.03

"Pills" and the air passages: a continuum. Chest (2015) 2.03

Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99

Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg (2008) 1.99

Common Congenital Anomalies of the Central Airways in Adults. Chest (2015) 1.96

Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91

Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88

Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg (2006) 1.80

Endobronchial fungal disease: an under-recognized entity. Respiration (2006) 1.78

Truncus arteriosus associated with interrupted aortic arch in 50 neonates: a Congenital Heart Surgeons Society study. Ann Thorac Surg (2006) 1.78

Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74

Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol (2008) 1.74

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72

Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71

What is the preferred therapy for patients with aortic coarctation--the standard gamble and decision analysis versus real results? Cardiol Young (2007) 1.71

Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg (2006) 1.71

Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71

A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69

Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg (2003) 1.69

A novel running annuloplasty suture technique for robotically assisted mitral valve repair. J Thorac Cardiovasc Surg (2010) 1.68

Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66

Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg (2002) 1.66

Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg (2003) 1.65

Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65

Socioeconomic status, Medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: Atherosclerosis Risk in Communities cohort (1987 to 2004). Circ Heart Fail (2011) 1.64

Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol (2002) 1.64

Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg (2008) 1.64

Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest (2003) 1.63

Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg (2009) 1.63

Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63

Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation (2006) 1.61

Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation (2002) 1.60

Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg (2006) 1.60

Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59

Does the arterial cannulation site for circulatory arrest influence stroke risk? Ann Thorac Surg (2004) 1.59

Ventilatory dependency after cardiovascular surgery. J Thorac Cardiovasc Surg (2007) 1.58

Robotic posterior mitral leaflet repair: neochordal versus resectional techniques. Ann Thorac Surg (2012) 1.57

Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.57